Nature Cancer February issue cover

Series on Cancer Immunotherapy

Check out our Series on the evolving palette of cancer immunotherapies, comprising Reviews, Perspectives and opinion pieces on the latest advances and challenges in clinical translation.


  • Illustration of tumor being eradicated by therapy.

    On May 22nd 2023 New York-based researchers focusing on RAS pathways in cancer will come together to discuss the recent foundational, translational and therapeutic advances. Registration is FREE!

  • Image of a painter's palette, Nature Cancer's June issue cover.

    Nature Cancer's Series on Cancer immunotherapy comprises commissioned Reviews, Perspectives and opinion pieces on the latest advances in the evolving palette of immunotherapies, the challenges in clinical translation of promising preclinical discoveries and their application to a wider patient population.

  • Nature Cancer pictorial

    View webcasts hosted by Nature Cancer editors, in which expert cancer researchers and clinicians discuss the most exciting advances and biggest challenges in their fields. Past events can be accessed on demand for free by registering your attendee details.

  • Nature Cancer Series Cover - image of medications in ingestible and injectable form.

    Nature Cancer presents a Series of commissioned Review and Perspective articles highlighting emerging concepts in cancer therapy, novel therapeutic approaches and the challenges in translating preclinical findings into clinical benefit, accompanied by a collection of relevant primary research and News and Comment articles published by Nature Cancer.

Nature Cancer is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


Image of different types of therapies, including pills and injectables, taken from the March 2021 issue cover of Nature Cancer.

Series on Cancer Therapy

Cancer therapy has advanced significantly in recent years, however, cancer remains a major health problem that requires further discovery and innovation to improve outcomes and quality of life for patients.